3,4-Dihydro Ivermectin

IMPURITIES

Product Details

CAT No.# CS-T-52965
Category Impurities
CAS 74567-01-4
Molecular Weight 877.11
Molecular Formula C48H76O14
Purity: >98%
Synonyms: (2R,4'S,5S,6R,8'R,10'E,12'S,13'S,14'E,16'E,20'R,21'R,24'S)-6- [(2S)-butan-2-yl]-21',24'-dihydroxy-12'- {[(2R,4S,5S,6S)-5-{[(2S,4S,5S,6S)-5-hydroxy-4- methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6- methyloxan-2-yl]oxy}-5,11',13',22'-tetramethyl- 3',7',19'-trioxaspiro[oxane-2,6'- teane]- 10',14',16'-trien-2'-one
Application Notes: 3,4-Dihydro Ivermectin is an impurity of Ivermectin , an antiparasitic drug that is active against a wide variety of nematode and arthropod parasites and is used to treat scabies and lice in humans.
References: Campbell, W., et al.: Science, 221, 823 (1983); Glaziou, P., et al.: Trop. Med. Parasitol., 45, 253 (1994); Meinking, T., et al.: New Engl. J. Med., 333, 26 (1995)
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
PEOPLE ALSO SEARCHED FOR: 1. (6R,7S)-7-(2-chloroacetamido)-7-methoxy-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
2. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
3. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
4. Benidipine D7
5. Lauroside D
6. Triazolam 13C D3
7. Icatibant impurity 1
8. BISPHENOL AF (RING-13C12)
9. 0.1% TFA in Water ULC-MS
10. Metamizole EP Impurity C HCl
11. Silodosin Metabolite D4
12. Brivaracetam Carboxylic acid metabolite [UCB 42145]
13. Terbuthylazine D5
14. tibolone (848)
15. (Z)-Dimethylvinphos
16. Silodosin Metabolite
17. 2-Phenoxymethanesulfonanilide
18. Nimesulide EP Impurity A
19. Acetone HPLC
20. Nandrolone Decanoate EP impurity F




This page contains information about 3,4-Dihydro Ivermectin Cas 74567-01-4 and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."